ArticleFrontiers in pharmacology2021

Efficacy and Safety of TangWang Prescription for Type 2 Non-Proliferative Diabetic Retinopathy: A Study Protocol for a Randomized Controlled Trial.

De Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.